Concepedia

Publication | Open Access

Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial

DOIFull Paper Access

51

Citations

32

References

2022

Year

Karim Fizazi, Margitta Retz, Daniel P. Petrylak, Jeffrey C. Goh, José Luis Perez‐Gracia, Louis Lacombe, Stefanie Zschäbitz, Mauricio Burotto, Hakim Mahammedi, Gwénaëlle Gravis,
Journal for ImmunoTherapy of Cancer

Abstract

NCT03338790.

References

YearCitations

Page 1